CNTB
Connect Biopharma Holdings Limited
NASDAQ · Healthcare · Biotechnology · CN
$1.84
−4.66%Aug 12, 2026, 20:05 UTC
Connect Biopharma Holdings Limited reported financial results for the second quarter of 2026, ending June 30, 2026.
Source:Jul 23, 2026, 06:15 UTC
Connect Biopharma raised net proceeds of $18.6 million in a private placement in the first quarter of 2026.
Source:Jun 17, 2026, 13:00 UTC
Connect Biopharma completed enrollment in its Phase 2 Seabreeze STAT Asthma study evaluating rademikibart for acute asthma exacerbations.
Source: